Acarbose

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Anabolic steroids, Beta blockers, Cholestyramine, Corticosteroids, Diazoxide, Digoxin, Diuretics, Estrogens, Hypoglycemic agents, MAO inhibitors, Neomycin, Orlistat, Pancreatin, Pegvisomant, Pramlintide, Progestogens, Somatropin, Testosterone

PREGNANCY CATEGORY: B

Contra-indicated in patients with diabetic ketoacidosis or cirrhosis; also in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction.

Our database has 16 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top